About us
Contact
Location
News
World News
Clinical News
UK News
Get news headlines by email
JobSearch
Search
Manage job postings
Recruiters' Directory
Get jobs by email
Advertising rates
Contacts
Magazine
Latest issue
Search past issues
Search Corporate profiles
Free subscription
Have your say
Advertising
Contact
Awards and Events
European Marketeer
Marketeer
RBM
Representative
Clinical Researcher
Communications Team
Recruiter
Great Oxford Debate
Joint Working Projects
US Clinical Researcher
Clubs
SOPHIE
PharmaTimes Directors' Club
Find agency
Advertising
Recruitment
Advertise
Why advertise?
Website and Archive search
Go
JobSearch
Go
Email
Password
Login
Subscribe to the archive
Forgotten password
MAGAZINE AUDIT BY
Where am I? >
Home
>
Industry News
>
Clinical News
LATEST CLINICAL NEWS
Pfizer, King’s College form open-innovation partnership for pain
Pfizer and King’s College London in the UK have announced an ‘open innovation’ partnership for pain research that will embed Pfizer scientists at the Wolfson Centre for Age-Related Diseases.
New global biostatistics infrastructure for Kendle
US-based contract research organisation Kendle has put in place a new global biostatistics infrastructure.
Kendle establishing operations centre in Indian economic zone
US-based contract research organisation Kendle has approval from the Indian authorities to set up an operations centre within a Special Economic Zone in the Ahmedabad-Gandhinagar Knowledge Corridor.
Karo Bio’s eprotirome shows marked LDL reduction in Phase II
A thyroid hormone analogue developed by Swedish company Karo Bio could significantly lower ‘bad’ cholesterol levels in patients already taking statins, and without any significant side-effects, the results of a Phase II trial suggest.
WuXi delivers on profit but guidance disappoints
WuXi PharmaTech, the international outsourcing company based in Shanghai, China, turned an operating loss of US$56.7 million into a US$13.6 million operating profit between the fourth quarters of 2008 and 2009.
Quintiles expands Phase I capacity in London
US-based biopharmaceutical services company Quintiles has opened an expanded facility for Phase I clinical trials at Guy’s Hospital in London, UK.
More Headlines
WuXi links with Janssen division on preclinical services
PPD opens contract research facility in Ireland
New microscopy technique could mean more effective beta-blockers
Celgene launches European hub for translational research
BUILD-3 results close avenue for Actelion’s Tracleer
Covance, Lilly add biotech services to strategic alliance
Chiltern, Charles River link on radiolabelled studies
Approval processes driving research teams from UK, study finds
PPD opens offices in Philippines, India
Quintiles offers centralised outreach with Trial Enrollment Accelerator
Academic Health Sciences Centre raises Tayside research profile
PA Consulting-4D Biomedical alliance follows translational lead
Older >
Join PharmaTimes Directors Club
Find out more
PharmaTimes Club for Directors Secretaries
Learn more
LATEST JOBS
Part-time Medical Representative
Account Manager/Senior Account Manager Flexible Remote Home Working
Market Access Specialist
Principal Analyst: Corporate
Compliance Manager
Junior Editor, Healthcare Communications
Product Specialist UK & Nordics or Asia Pacific - Healthcare
BUSINESS DEVELOPMENT MANAGER - HOMECARE
Project Director Pharmaceutical Market Research
PRODUCT MANAGER - HOMECARE
Home
|
World News
|
Clinical News
|
UK News
|
Magazines
|
Competitions
|
Clubs
|
Jobs
|
Forums
|
Directory
RSS Feed
|
Advertising & Rates
|
About us
|
Contact
|
Subscribe
|
Privacy
|
Statistics
|
Maintained by DCSL